Skyrizi and Abdominal pain - a phase IV clinical study of FDA data
Summary:
Abdominal pain is reported as a side effect among people who take Skyrizi (risankizumab-rzaa), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Prednisone, and have Crohn's disease.
The phase IV clinical study analyzes which people have Abdominal pain when taking Skyrizi. It is created by eHealthMe based on reports of 45,344 people who have side effects when taking Skyrizi from the FDA, and is updated regularly.
What is Skyrizi?
Skyrizi has active ingredients of risankizumab-rzaa. eHealthMe is studying from 45,385 Skyrizi users. Check the latest studies of Skyrizi.
What is Abdominal pain?
Abdominal pain is found to be associated with 3,226 drugs and 5,748 conditions by eHealthMe. Check the latest studies of Abdominal pain.
45,344 people reported to have side effects when taking Skyrizi.
Among them, 400 people (0.88%) have Abdominal pain.

Among these 400 people:
How long have people been on Skyrizi when they have Abdominal pain? *
What is the gender of people who have Abdominal pain when taking Skyrizi? *
What is the age of people who have Abdominal pain when taking Skyrizi? *
What are other drugs people take besides Skyrizi? *
What are other side effects people have besides Abdominal pain? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Skyrizi and have Abdominal pain?
- Check whether Abdominal pain is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Skyrizi:
- Skyrizi (45,385 reports)
Abdominal pain treatments and more:
- Abdominal pain (286,410 reports)
How severe was Abdominal pain and when was it recovered:
Expand to all the drugs that have ingredients of risankizumab-rzaa:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Skyrizi:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Abdominal pain:
- Abdominal pain (3,226 drugs)
Browse all the conditions that are associated with Abdominal pain:
- Abdominal pain (5,748 conditions)
Related publications that referenced our studies
- Bhuvan KC, ALrasheedy AA, Ibrahim MI, "A case report from Nepalese community pharmacy on levofloxacin induced severe abdominal pain", Saudi Pharmaceutical Journal, 2013 Jul .
- Bhuvan KC, ALrasheedy AA, Ibrahim MI, "A case report from Nepalese community pharmacy on levofloxacin induced severe abdominal pain", Saudi Pharmaceutical Journal, 2013 Jul .
How the study uses the data?
The study uses data from the FDA. It is based on risankizumab-rzaa (the active ingredients of Skyrizi) and Skyrizi (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Abilify cause Limb Reduction Defect? - 4 seconds ago
- Could Cosentyx cause Faeces Hard? - 13 seconds ago
- Drug interactions of Aleve and Pentasa - 22 seconds ago
- Sofosbuvir and Fever for Men aged 60+ - 25 seconds ago
- Sofosbuvir and Heat Stroke for Men aged 60+ - 26 seconds ago
- Sofosbuvir and Pyrexia for Men aged 60+ - 26 seconds ago
- Sofosbuvir and Hyperthermia for Men aged 60+ - 26 seconds ago
- Sofosbuvir and Elevated Temperature for Men aged 60+ - 26 seconds ago
- Sofosbuvir and Body Overheating for Men aged 60+ - 27 seconds ago
- Drug interactions of Felodipine and Lotensin - 31 seconds ago